- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Transition zone PSA density improves the prostate cancer detection rate both in PSA 4.0-10.0 and 10.1-20.0 ng/ml in Chinese men - Abstract
September 19, 2011
Circulating and disseminated tumor cells in the management of advanced prostate cancer - Abstract
September 19, 2011
Genetics may explain why calcium increases risk for prostate cancer
September 19, 2011
Prostate cancer can be detected even in patients with decreased PSA less than 2.5 ng/ml after treatment of chronic prostatitis - Abstract
September 16, 2011
Suitability of PSA-detected localised prostate cancers for focal therapy: Experience from the ProtecT study - Abstract
September 16, 2011
Anatomical and clinical predictors of acute bowel toxicity in whole pelvis irradiation for prostate cancer with Tomotherapy - Abstract
September 16, 2011
Treating intermediate-risk prostate cancer with hypofractionated external beam radiotherapy alone - Abstract
September 16, 2011
Gleason score 7 prostate cancer on needle biopsy: Relation of primary pattern 3 or 4 to pathological stage and progression after radical prostatectomy - Abstract
September 15, 2011
Emerging therapies to prevent skeletal morbidity in men with prostate cancer - Abstract
September 15, 2011
Construct validity in a high-fidelity prostate exam simulator - Abstract
September 15, 2011
Role of pelvic lymph node dissection in prostate cancer treatment - Abstract
September 15, 2011
Prostate-specific antigen testing across the spectrum of prostate cancer - Abstract
September 15, 2011
Active-targeted nanotherapy strategies for prostate cancer - Abstract
September 15, 2011